Cargando…
Chromosomal Microarray Analysis as First-Tier Genetic Test for Schizophrenia
Schizophrenia is a chronic, devastating mental disorder with complex genetic components. Given the advancements in the molecular genetic research of schizophrenia in recent years, there is still a lack of genetic tests that can be used in clinical settings. Chromosomal microarray analysis (CMA) has...
Autores principales: | Chen, Chia-Hsiang, Cheng, Min-Chih, Hu, Tsung-Ming, Ping, Lieh-Yung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517076/ https://www.ncbi.nlm.nih.gov/pubmed/34659328 http://dx.doi.org/10.3389/fgene.2021.620496 |
Ejemplares similares
-
Detection of Rare Methyl-CpG Binding Protein 2 Gene Missense Mutations in Patients With Schizophrenia
por: Chen, Chia-Hsiang, et al.
Publicado: (2020) -
Chromosomal microarray analysis as a first-tier clinical diagnostic test: Estonian experience
por: Žilina, Olga, et al.
Publicado: (2014) -
Challenging diagnoses of tetraploidy/diploidy and trisomy 12: utility of first-tier prenatal testing methods
por: Iordanescu, Irina Ioana, et al.
Publicado: (2023) -
Chromosomal microarray analysis as the first-tier test for the identification of pathogenic copy number variants in chromosome 9 pericentric regions and its challenge
por: Wang, Jia-Chi, et al.
Publicado: (2016) -
Potentials and challenges of chromosomal microarray analysis in prenatal diagnosis
por: Liu, Xijing, et al.
Publicado: (2022)